Psyence Group Announces C$600,000 Private Placement to Fund Strategic Growth - TipRanks.com

▤ Summary

Psyence Group announced a non-brokered private placement to raise up to C$600,000 by issuing up to 6,000,000 common shares at C$0.10 each. The company said it will use the proceeds to pursue strategic transactions, including possible acquisitions or business combinations, and to cover general administrative costs. Psyence also said the funds may help it maintain listing status while it works through business needs and market conditions. The deal is expected to close around June 25, 2025, pending regulatory approvals. Psyence Group operates as a life science biotechnology company focused on natural psychedelics and psilocybin products.

$ Funding

▦ Linked Companies